CM
ANAB icon

Caption Management’s AnaptysBio ANAB Stock Holding History

Caption Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,376
Closed -$435K – 1415
2025
Q1 		$435K Buy
23,376
+15,834
+210% +$264K ﹤0.01% 1133
2024
Q4 		$99.9K Buy
+7,542
New +$183K ﹤0.01% 1335
2024
Q1 		– Sell
-17,004
Closed -$364K – 1167
2023
Q4 		$364K Hold
17,004
– – ﹤0.01% 1030
2023
Q3 		$305K Buy
17,004
+13,585
+397% +$259K ﹤0.01% 1039
2023
Q2 		$69.5K Buy
+3,419
New +$69.3K ﹤0.01% 997
2021
Q2 		– Sell
-6,000
Closed -$129K – 1274
2021
Q1 		$129K Sell
6,000
-8,157
-58% -$206K ﹤0.01% 949
2020
Q4 		$305K Sell
14,157
-7,943
-36% -$193K 0.01% 796
2020
Q3 		$326K Sell
22,100
-66,664
-75% -$1.2M 0.01% 843
2020
Q2 		$1.98M Sell
88,764
-16,836
-16% -$308K 0.07% 387
2020
Q1 		$1.49M Buy
105,600
+45,577
+76% +$691K 0.08% 313
2019
Q4 		$976K Buy
60,023
+14,023
+30% +$332K 0.03% 506
2019
Q3 		$1.61M Buy
+46,000
New +$2.19M 0.08% 282

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Caption Management's ANAB Position: Q2 2025 in Review

Caption Management sold out of AnaptysBio (ANAB) in Q2 2025, closing a stake of 23,376 shares — an estimated $435K sold.

Caption Management first reported a position in ANAB in Q3 2019 and held it in 12 quarters. The position peaked at $1.98M in Q2 2020. 147 funds tracked by Wall St. Rank hold ANAB as of Q2 2025.

  • Caption Management reported no remaining AnaptysBio position as of Q2 2025 after selling out during the quarter.
  • Caption Management sold 23,376 AnaptysBio shares in Q2 2025, an estimated $435K.
  • Caption Management first reported a position in AnaptysBio in Q3 2019 and held it in 12 quarters.
  • Caption Management's AnaptysBio position peaked at $1.98M in Q2 2020.
  • 147 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.